Critical Reviews in Oncology / Hematology
Volume 79, Issue 1 , Pages 84-90, July 2011

Enteropathy-associated T-cell lymphoma

  • Andrés J.M. Ferreri

      Affiliations

    • Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
    • Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
    • Corresponding Author InformationCorresponding author at: Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy. Tel.: +39 02 26437649; fax: +39 02 26437625.
  • ,
  • Pier Luigi Zinzani

      Affiliations

    • Clinical Unit, Department of Haematology and Oncological Sciences “L. and A. Seràgnoli”, Bologna University School of Medicine, Bologna, Italy
  • ,
  • Silvia Govi

      Affiliations

    • Unit of Lymphoid Malignancies, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
    • Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, Milan, Italy
  • ,
  • Stefano A. Pileri

      Affiliations

    • Haematopathology Unit, Department of Haematology and Oncological Sciences “L. and A. Seràgnoli”, Bologna University School of Medicine, Bologna, Italy

Accepted 25 June 2010. published online 26 July 2010.

Abstract 

Enteropathy-associated T-cell lymphoma (EATL) is an intestinal tumour of intraepithelial T lymphocytes, usually presenting as a neoplasm composed of large lymphoid cells and often associated with necrosis and an inflammatory background, including large numbers of histiocytes and eosinophils. Intestinal intraepithelial α–β T-cells have been postulated as the normal-cell counterpart for EATL. EATL is the most common neoplastic complication of coeliac disease. The disease is uncommon in most parts of the world, but is seen with greater frequency in those areas with a high prevalence of coeliac disease, in particular Northern Europe. Usually, EATL occurs in adults, and generally present with abdominal pain, often associated with jejunal perforation, weight loss, diarrhoea, or bowel obstruction. EATL is characterized by multifocal presentation in 10–25% of cases. Small-bowel lymphoma is more common than large-bowel or rectal lymphomas. The prognosis of EATL is very poor, with low chemosensitivity, rapid tumour growth and a tendency to dissemination. Moreover, the high incidence of severe postsurgical complications and the poor nutritional and immunological conditions lead to progressive deterioration of these patients, preventing the use of an adequate and effective treatment.

Keywords: T-cell lymphoma, Intestinal lymphoma, Coeliac disease, Malabsorption

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1040-8428(10)00149-6

doi:10.1016/j.critrevonc.2010.06.006

Critical Reviews in Oncology / Hematology
Volume 79, Issue 1 , Pages 84-90, July 2011